Navigation Links
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Date:10/2/2008

rsity in the United States. The university's emphasis on both learning and research-and on how each complements the other-revolutionized U.S. higher education. Today, Johns Hopkins has ventured from its home in Baltimore to countries throughout the world-China, Italy and Singapore, among many others. It remains a world leader in teaching, patient care and discovery.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNAs. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The first microRNA diagnostic test applying Rosetta Genomics' technology has been approved for clinical use by the State of New York, and the company expects it will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease, Rosetta's ability to successfully develop a test differentiating Squamous NSCLC from other NSCLC and the expected timing of commercial launch of tests using Rosetta's microRNA technology, constitute forward-looking s
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
2. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
3. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
4. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
5. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
6. Queens University Chooses Xceeds Ziplex(R) System for Translational Research
7. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
8. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
9. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
10. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
11. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... and NYSE: SNY ) today announced that ... people with hypercholesterolemia met their primary efficacy endpoint of ... cholesterol (LDL-C) at 24 weeks compared to placebo or ... PCSK9 (proprotein convertase subtilisin/kexin type 9). In ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Eisai ... announced today that an article based on post-hoc analyses from ... Weight Loss While on Lorcaserin, Diet, and Exercise as a ... the online issue of Obesity , the official peer ... analyses was to identify whether there is an early treatment ...
(Date:7/30/2014)... 2014  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), ... its expertise in opioid antagonists, announced today that ... prominent international research and development foundation. ... research-based initiatives, including those addressing health issues. Lightlake ... delivery of naloxone that could widely expand its ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3
... April 29 Wellcore Corporation, a Silicon Valley-based ... safety, begins shipping its highly anticipated Wellcore system today. ... live more active, independent lives, the Wellcore system offers ... will work outside of the home, unlike other fall ...
... on pharma industry , , , ... two whistleblower lawsuits that is being settled as part of Ortho-McNeil-Janssen Pharmaceuticals Inc.,s and Ortho-McNeil Pharmaceutical LLC,s ... northern Virginia . , , , ... , , ...
Cached Medicine Technology:The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available 2The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available 3Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 2Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 3Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 4
(Date:7/30/2014)... news of an Ohio teen who died of a ... the normally well-tolerated and mass-consumed substance. To help prevent ... much caffeine, scientists are reporting progress toward a rapid, ... stimulant in most beverages and even breast milk. Their ... Food Chemistry . , Mani Subramanian and colleagues note ...
(Date:7/30/2014)... Los Angeles, CA (PRWEB) July 30, 2014 ... Ghasri, now offers comprehensive cosmetic dental treatments that can ... office, Sunset Plaza Dental. Healthy teeth and gums form ... affect a person’s smile. While minor chips, misshapen teeth ... can all detract from a smile’s appearance. The right ...
(Date:7/30/2014)... 2014 All the children at Father’s ... rejection, abuse and exploitation tend to mar their respective ... and dejection. Quality youth development has underpinnings in a ... boosts confidence and in the foreseeable future, would assist ... light that the mere presence of Foundation members in ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- ,Middle-aged adults ... twice as likely as others to develop severe memory ... The British researchers said their findings could help ... might benefit from help for problem drinking. "We ... and levels of current alcohol consumption -- that understanding ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 We know pregnancy ... to peanut butter and ice cream—but the latest episode of ... MDs , just posted online, has a recipe that is ... a James Beard Award-winning chef serves up an easy recipe ... is the executive chef at Rasika, which was named one ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2Health News:What to Eat When You’re Expecting 2
... Duke University Medical Center researchers, African-Americans have a notably ... hepatitis C than non-Hispanic whites. ,The ... which is the journal for the members of the ... with hepatitis C (HCV) infections experience a reduced response ...
... A new study published in the Journal of Neurology, Neurosurgery ... during //two peak periods. Japanese researchers who conducted the study ... and 8am and 6pm and 8pm. ,The researchers examined ... was lowest during sleep. This may probably be due to ...
... Health Service Executive in Ireland is all set to offer ... overcrowding.// ,The Irish Examiner reports that hospitals may be ... the A&E crisis, where patients are made to wait for ... patients are not made to wait over 24 hours. Also ...
... University of Siena, researchers found that cartoons are twice as ... medical procedures, such as having a blood sample taken. ... Scatte Clinic divided 69 children, aged between 7 and 12, ... kids started watching TV cartoons at least two minutes before ...
... a little extra income can make a big difference in helping ... the upper end," said Meredith Minkler, an author of a report ... England Journal of Medicine. "We always knew there was a major ... that the middle class was at a substantial disadvantage to slightly ...
... west of Scotland; Inverclyde, is to be revamped.// ... and increase in the range of community-based services will ... ,An already existing ward at Inverclyde Royal Hospital ... Children's hospital services, therapy services currently provided by ...
Cached Medicine News:Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 2Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 3Health News:The higher the income the lower the disability rates! 2Health News:A new deal for childcare services given go-ahead 2
... is a primary component of an integrated ... sampling, and slide preparation all strictly ... LBP Processor produces high-quality sample slides featuring ... of cytology specimen types. It processes 40 ...
... offer a safe alternative to using positive ... applications such as PCR(a), pipetting radioactive materials ... are excellent for tissue culture, gel loading, ... prevent aerosol contaminants and liquids from reaching ...
... Packed conveniently in plastic-wrapped racks of ... to useno need to autoclave. Sterilized Diamond ... efficient sterilization and are delivered with a ... irradiation. Sterilized Diamond Tips are certified free ...
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
Medicine Products: